Published 16 May 2005. doi:10.1084/jem.20041044
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 10, 1647-1657
TGF-ßdependent CD103 expression by CD8+ T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease
Riham El-Asady2,
Rongwen Yuan1,
Kechang Liu2,
Donghua Wang1,
Ronald E. Gress4,
Philip J. Lucas4,
Cinthia B. Drachenberg3, and
Gregg A. Hadley1,2
1 Department of Surgery, University of Maryland Medical School, Baltimore, MD 21201
2 Department of Microbiology and Immunology, University of Maryland Medical School, Baltimore, MD 21201
3 Department of Pathology, University of Maryland Medical School, Baltimore, MD 21201
4 Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892
CORRESPONDENCE Gregg A. Hadley: ghadley{at}smail.umaryland.edu
Destruction of the host intestinal epithelium by donor effector T cell populations is a hallmark of graft-versus-host disease (GVHD), but the underlying mechanisms remain obscure. We demonstrate that CD8+ T cells expressing CD103, an integrin conferring specificity for the epithelial ligand E-cadherin, play a critical role in this process. A TCR transgenic GVHD model was used to demonstrate that CD103 is selectively expressed by host-specific CD8+ T cell effector populations (CD8 effectors) that accumulate in the host intestinal epithelium during GVHD. Although host-specific CD8 effectors infiltrated a wide range of host compartments, only those infiltrating the intestinal epithelium expressed CD103. Host-specific CD8 effectors expressing a TGF-ß dominant negative type II receptor were defective in CD103 expression on entry into the intestinal epithelium, which indicates local TGF-ß activity as a critical regulating factor. Host-specific CD8 effectors deficient in CD103 expression successfully migrated into the host intestinal epithelium but were retained at this site much less efficiently than wild-type host-specific CD8 effectors. The relevance of these events to GVHD pathogenesis is supported by the finding that CD103-deficient CD8+ T cells were strikingly defective in transferring intestinal GVHD pathology and mortality. Collectively, these data document a pivotal role for TGF-ßdependent CD103 expression in dictating the gut tropism, and hence the destructive potential, of CD8+ T cells during GVHD pathogenesis.
Abbreviations used: B6, C57BL/6; BMC, BM cells; BMT, BM transplantation; CD8 effectors, CD8+ T cell effector populations; CFSE, carboxy- fluorescein diacetate succinimidyl ester; DNR, dominant negative TGF-ß type II receptor; GVHD, graft-versus-host disease; H&E, hematoxylin and eosin; hsCD8eff, host-specific CD8 effectors; MLN, mesenteric LNs; MST, mean survival time; SC, spleen cells; TCR-Tg, TCR transgenic.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Article
-
Gut-grabbing T cells trigger GVHD
- Heather L. Van Epps
J. Exp. Med. 2005 201: 1521.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Jaensson, E., Uronen-Hansson, H., Pabst, O., Eksteen, B., Tian, J., Coombes, J. L., Berg, P.-L., Davidsson, T., Powrie, F., Johansson-Lindbom, B., Agace, W. W.
(2008). Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. JEM
205: 2139-2149
[Abstract]
[Full Text]
-
Schlickum, S., Sennefelder, H., Friedrich, M., Harms, G., Lohse, M. J., Kilshaw, P., Schon, M. P.
(2008). Integrin {alpha}E(CD103){beta}7 influences cellular shape and motility in a ligand-dependent fashion. Blood
112: 619-625
[Abstract]
[Full Text]
-
Adams, D H, Eksteen, B, Curbishley, S M
(2008). Immunology of the gut and liver: a love/hate relationship. Gut
57: 838-848
[Full Text]
-
Di Sabatino, A, Pickard, K M, Rampton, D, Kruidenier, L, Rovedatti, L, Leakey, N A B, Corazza, G R, Monteleone, G, MacDonald, T T
(2008). Blockade of transforming growth factor {beta} upregulates T-box transcription factor T-bet, and increases T helper cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa. Gut
57: 605-612
[Abstract]
[Full Text]
-
Zhou, S., Ueta, H., Xu, X.-D., Shi, C., Matsuno, K.
(2008). Predominant donor CD103+CD8+ T cell infiltration into the gut epithelium during acute GvHD: a role of gut lymph nodes. Int Immunol
20: 385-394
[Abstract]
[Full Text]
-
Beilhack, A., Schulz, S., Baker, J., Beilhack, G. F., Nishimura, R., Baker, E. M., Landan, G., Herman, E. I., Butcher, E. C., Contag, C. H., Negrin, R. S.
(2008). Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Blood
111: 2919-2928
[Abstract]
[Full Text]
-
Kim, T. D., Terwey, T. H., Zakrzewski, J. L., Suh, D., Kochman, A. A., Chen, M. E., King, C. G., Borsotti, C., Grubin, J., Smith, O. M., Heller, G., Liu, C., Murphy, G. F., Alpdogan, O., van den Brink, M. R. M.
(2008). Organ-derived dendritic cells have differential effects on alloreactive T cells. Blood
111: 2929-2940
[Abstract]
[Full Text]
-
Saurer, L., McCullough, K. C., Summerfield, A.
(2007). In Vitro Induction of Mucosa-Type Dendritic Cells by All-Trans Retinoic Acid. J. Immunol.
179: 3504-3514
[Abstract]
[Full Text]
-
Masson, F., Calzascia, T., Di Berardino-Besson, W., de Tribolet, N., Dietrich, P.-Y., Walker, P. R.
(2007). Brain Microenvironment Promotes the Final Functional Maturation of Tumor-Specific Effector CD8+ T Cells. J. Immunol.
179: 845-853
[Abstract]
[Full Text]
-
Floc'h, A. L., Jalil, A., Vergnon, I., Chansac, B. L. M., Lazar, V., Bismuth, G., Chouaib, S., Mami-Chouaib, F.
(2007). {alpha}E{beta}7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. JEM
204: 559-570
[Abstract]
[Full Text]
-
Ling, K.-L., Dulphy, N., Bahl, P., Salio, M., Maskell, K., Piris, J., Warren, B. F., George, B. D., Mortensen, N. J., Cerundolo, V.
(2007). Modulation of CD103 Expression on Human Colon Carcinoma-Specific CTL. J. Immunol.
178: 2908-2915
[Abstract]
[Full Text]
-
Menoret, A., Myers, L. M., Lee, S.-J., Mittler, R. S., Rossi, R. J., Vella, A. T.
(2006). TGFbeta Protein Processing and Activity through TCR Triggering of Primary CD8+ T Regulatory Cells. J. Immunol.
177: 6091-6097
[Abstract]
[Full Text]
-
Degauque, N., Lair, D., Dupont, A., Moreau, A., Roussey, G., Moizant, F., Hubert, F. X., Louvet, C., Hill, M., Haspot, F., Josien, R., Usal, C., Vanhove, B., Soulillou, J. P., Brouard, S.
(2006). Dominant Tolerance to Kidney Allografts Induced by Anti-Donor MHC Class II Antibodies: Cooperation between T and Non-T CD103+ Cells. J. Immunol.
176: 3915-3922
[Abstract]
[Full Text]
-
Annacker, O., Coombes, J. L., Malmstrom, V., Uhlig, H. H., Bourne, T., Johansson-Lindbom, B., Agace, W. W., Parker, C. M., Powrie, F.
(2005). Essential role for CD103 in the T cell-mediated regulation of experimental colitis. JEM
202: 1051-1061
[Abstract]
[Full Text]
-
Johansson-Lindbom, B., Svensson, M., Pabst, O., Palmqvist, C., Marquez, G., Forster, R., Agace, W. W.
(2005). Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing. JEM
202: 1063-1073
[Abstract]
[Full Text]
-
Yuan, R., El-Asady, R., Liu, K., Wang, D., Drachenberg, C. B., Hadley, G. A.
(2005). Critical Role for CD103+CD8+ Effectors in Promoting Tubular Injury following Allogeneic Renal Transplantation. J. Immunol.
175: 2868-2879
[Abstract]
[Full Text]